Meropenem 1 G Injection 500 mg, 1 g, 2 g per vial Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV)
Available Strengths: 500 mg, 1 g, 2 g per vial
Reference Brands: Merrem (US & EU)
Category: Antibiotics
Meropenem inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, causing bacteria to lyses and die. It offers broad-spectrum activity against resistant gram-negative and gram-positive bacteria, including Pseudomonas. Benefits include rapid bactericidal effect, good tissue penetration, and suitability for severe, life-threatening infections in hospital settings.
Product Description:
Meropenem IV is approved in the EU and US for severe bacterial infections, including pneumonia, meningitis, and intra-abdominal infections. In the EU, brands like Merrem are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on extensive clinical data, with generic options available. Both regions require detailed dossiers, including clinical trial results, quality control, and pharmacovigilance plans for approval and safety monitoring. Due to its critical role in fighting resistant infections, strict prescribing controls and safety guidelines are enforced. For regulatory support and dossier assistance, visit PharmaTradz. We support seamless market access while ensuring adherence to European and US standards.
Meropenem 1 G Injection — third party manufacturing & bulk supply
Meropenem 1 G Injection 500 mg, 1 g, 2 g per vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Meropenem 1 G Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Meropenem 1 G Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Meropenem is used to treat serious bacterial infections such as complicated intra-abdominal infections, meningitis, hospital-acquired pneumonia, and complicated skin and soft tissue infections. It is commonly administered in hospitals for infections caused by susceptible bacteria.
Meropenem is made from the active pharmaceutical ingredient meropenem trihydrate, a broad-spectrum carbapenem antibiotic that works by inhibiting bacterial cell wall synthesis and stopping the growth of bacteria.
Common trade names include Merrem and Merosan.
The originator brand Merrem was developed and marketed by AstraZeneca. Generic versions including Merosan and other brands are manufactured by various pharmaceutical companies globally.
The generic name is meropenem trihydrate.
Brand names include Merrem and Merosan.
Meropenem injections are manufactured in several countries including the United States, European countries, India, and Latin American regions in pharmaceutical facilities that follow regulatory standards such as US FDA, EMA, and other national authorities.
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
